Ivan S. Coulter
Corporate Officer/Principal bij Irish Research Council
Profiel
Ivan S.
Coulter was the founder of Sublimity Therapeutics Ltd.
founded in 2003, where he held the position of Chief Executive Officer & Director until 2018.
He is currently a Member of the Irish Research Council and an Advisor at IIF Management Co. LLC since 2022.
Dr. Coulter's former positions include Chief Executive Officer of Atxa Therapeutics Ltd.
from 2018 to 2019, Board Member of Bord Iascaigh Mhara from 2007 to 2011, Chief Technology Officer of Sublimity Therapeutics Ltd.
in 2018, and Chief Executive & Technology Officer of Sublimity Therapeutics Ltd.
from 2003 to 2018.
Dr. Coulter's education history includes an MBA from Cornell University in 2000 and undergraduate and doctorate degrees from University College Dublin.
Actieve functies van Ivan S. Coulter
| Bedrijven | Functie | Begin |
|---|---|---|
| Irish Research Council | Corporate Officer/Principal | - |
IIF Management Co. LLC
 IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Consultant / Adviseur | 01-08-2022 |
Eerdere bekende functies van Ivan S. Coulter
| Bedrijven | Functie | Einde |
|---|---|---|
Atxa Therapeutics Ltd.
 Atxa Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Atxa Therapeutics Ltd. is an Irish private company located in Belfield that operates as a pharmaceutical company that engages in research and development of committed to advancement of life-changing treatments for cardiopulmonary diseases. | Chief Investment Officer | 02-12-2019 |
Sublimity Therapeutics Ltd.
 Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Hoofd Techniek/Wetenschap/O&O | 02-09-2018 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Algemeen Directeur | 02-05-2018 |
| Bord Iascaigh Mhara | Directeur/Bestuurslid | 02-08-2011 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Oprichter | - |
Opleiding van Ivan S. Coulter
| University College Dublin | Doctorate Degree |
| Cornell University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
| Irish Research Council | |
Atxa Therapeutics Ltd.
Atxa Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Atxa Therapeutics Ltd. is an Irish private company located in Belfield that operates as a pharmaceutical company that engages in research and development of committed to advancement of life-changing treatments for cardiopulmonary diseases. | Commercial Services |
| Bord Iascaigh Mhara | |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Finance |